Early liver function improvement following successful treatment of chronic hepatitis C in patients with decompensated cirrhosis: a real-life study

OBJECTIVES: Despite higher rates of sustained virologic response (SVR), important concerns remain when patients with decompensated cirrhosis due to hepatitis C virus (HCV) are treated with direct-acting antiviral agents (DAA). Questions include efficacy, safety, and the magnitude of liver function i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenço, Mariana Sandoval, Zitelli, Patricia Momoyo Y., Cunha-Silva, Marlone, Oliveira, Arthur Ivan N., de Lima, Roque Gabriel Rezende, Evandro de Oliveira, Souza, Oliveira, Claudia P., Sevá-Pereira, Tiago, Carrilho, Flair J., Pessoa, Mario G., Mazo, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579851/
https://www.ncbi.nlm.nih.gov/pubmed/34817045
http://dx.doi.org/10.6061/clinics/2021/e3186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579851/
https://www.ncbi.nlm.nih.gov/pubmed/34817045
http://dx.doi.org/10.6061/clinics/2021/e3186

Ejemplares similares